Regulation of dauer larva development in Caenorhabditis elegans by daf-18, a homologue of the tumour suppressor PTEN

Current Biology

Volumn 9, Issue 6, 1999, Pages 329-334

  Rouault, Jean Pierre ^a   Kuwabara, Patricia E ^b   Sinilnikova, Olga M ^c   Duret, Laurent ^d   Thierry Mieg, Danielle ^e   Billaud, Marc ^c  

^a CENTRE LÉON BÉRARD   (France)

^b MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^c CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

^d UNIVERSITÉ LYON 1   (France)

^e Centre National de la Recherche Scientifique   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; CAENORHABDITIS ELEGANS; INVERTEBRATA; VERMES;

EID: 0033602383     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9822(99)80143-2     Document Type: Article

References (31)

1. Li D-M, Sun H: TEP1, encoded by a candidate tumour suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor β. Cancer Res 1997, 57:2124-2129.
2. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, et al.: PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast and prostate cancer. Science 1997, 275:1943-1947.
3. Steck PA, Pershouse Ma, Jasser SA, Yung AWK, Lin H, Ligon AH, et al.: Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 1997, 15:356-362.
4. Eng C, Parsons R: Cowden disease. Cowden syndrome. In The Metabolic and Molecular Bases of Inherited Disease, 8th Edn. Edited by Scriver CR, Beaudet AL, Sly WS, Valle D, Vogelstein B, Childs B. New York: McGraw Hill; in press.
5. Myers MP, Stolarov JP, Eng C, Li J, Wang SI, Wigler MH, et al.: PTEN, the tumour suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc Natl Acad Sci USA 1997, 94:9052-9057.
6. Tamura M, Gu J, Matsumo K, Aota S, Parsons R, Yamada KM: Inhibition of cell migration, spreading and focal adhesions by tumour suppressor PTEN. Science 1998, 280:1614-1617.
7. Gu J, Tamura M, Yamada KM: Tumor suppressor PTEN inhibits integrin-and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways. J Cell Biol 1998, 143:1375-1383.
8. Maehama T, Dixon JE: The tumour suppressor PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-triphosphate. J Biol Chem 1998, 273:13375-13378.
9. RiddLe DL, Albert P: Genetic and environmental regulation of dauer larva development. In C. Elegans II. Edited by Riddle DL, Blumenthal T, Meyer BJ, Priess JR. Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 1997:739-768.
10. Haynie DT, Ponting CP: The n-terminal domains of tensin and auxilin are phosphatase homologues. Protein Sci 1996, 5:2643-2646.
11. Morris JZ, Tissenbaum HA, Ruvkun G: A phosphatidylinositol-3-oh kinase family member regulating longevity and diapause in caenorhabditis elegans. Nature 1996, 382:536-539.
12. Friedman DB, Johnson TE: A mutation in the age-1 gene in caenorhabditis elegans lengthens life and reduces hermaphrodite fertility. Genetics 1988, 118:75-86.
13. Gottlieb S, Ruvkun G: Daf-2, daf-16 and daf-23: Genetically interacting genes controlling dauer formation in caenorhabditis elegans. Genetics 1994, 137:107-120.
14. Dorman JB, Albinder B, Shroyer T, Kenyon C: The age-1 and daf-2 genes function in a common pathway to control the lifespan of caenorhabditis elegans. Genetics 1995, 141:1399-1406.
15. Larsen PL, Albert PS, RiddLe DL: Genes that regulate both development and longevity in caenorhabditis elegans. Genetics 1995, 139:1567-1583.
16. Lithgow GJ: Invertebrate gerontology: The age mutations of caenorhabditis elegans. Bioessays 1996, 18:809-815.
17. Kimura KD, Tissenbaum HA, Liu Y, Ruvkun G: Daf-2, an insulin receptor-like gene that regulates longevity and diapause in caenorhabditis elegans. Science 1997, 277:942-946.
18. Lin K, Dorman JB, Rodan A, Kenyon C: Daf-16: An hnf-3/forkhead family member that can function to double the life-span of caenorhabditis elegans. Science 1997, 278:1319-1322.
19. Ogg S, Paradis S, Gottlieb S, Patterson GI, Lee L, Tissenbaum HA, Ruvkun G: The fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans. Nature 1997, 389:994-999.
20. Paradis S, Ruvkun G: Caenorhabditis elegans Akt/PKB transduces insulin receptor-like signals from AGE-1 PI3 kinase to the DAF-16 transcription factor. Genes Dev 1998, 12:2488-2498.
21. Vowels JJ, Thomas JH: Genetic analysis of chemosensory control of dauer formation in caenorhabditis elegans. Genetics 1992, 130:105-123.
22. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC: Potent and specific genetic interference by double-stranded RNA in caenorhabditis elegans. Nature 1998, 391:806-811.
23. Apfeld J, Kenyon C: Cell nonautonomy of C. elegans daf-2 function in the regulation of diapause and life span. Cell 1998, 95:199-210.
24. VanhaeseBroeck B, Leevers SJ, Panayotou G, Waterfield MD: Phosphoinositide 3-kinases: A conserved family of signal transducers. Trends Biochem Sci 1997, 22:267-272.
25. Bellacosa A, De Feo D, Godwin AK, Bell DW, Cheng JQ, Altomare DA, et al.: Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas. Int J Cancer 1995, 64:280-285.
26. Cheng JQ, Ruggeri B, Klein WM, Sonoda G, Altomare DA, Watson DK, Testa JR: Amplification of AKT2 in human pancreatic cancer cells and inhibition of AKT2 expression and tumourigenicity by antisense RNA. Proc Natl Acad Sci USA 1996, 93:3636-3641.
27. Shayesteh L, Lu Y, Kuo W-L, Baldocchi R, Godfrey T, COllins C, et al.: PIK3CA is implicated as an oncogene in ovarian cancer. Nat Genet 1999, 21:99-102.
28. Stambolic V, Suzuki A, De La Pompa JL, Brothers GM, Mirtsos C, Sasaki, T, et al.: Negative regulation of PKB/Akt-dependent cell survival by the tumour suppressor PTEN. Cell 1998, 95:29-39.
29. Haas-Kogan D, Shalev N, Wong M, Mills G, Yount G, Stokoe D: Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumour suppressor PTEN/MMAC. Curr Biol 1998, 8:1195-1198.
30. Myers MP, Pass I, Batty IH, Van der Kaay J, Stolarov JP, Hemmings BA, et al.: The lipid phosphatase activity of PTEN is critical for its tumour suppressor function. Proc Natl Acad Sci USA 1998, 95:13513-13518.
31. Ogg S, Ruvkun G: The C. elegans PTEN homologue, DAF-18, acts in the insulin receptor-like metabolic signaling pathway. Mol Cell 1998, 2:887-893.